New COVID Shot Targeting Omicron Could Be Available in September
September 02, 2022
Pfizer and Moderna have developed new vaccines designed to target COVID's omicron mutation. Both manufacturers have asked the U.S. Food and Drug Administration to green-light their versions of the jab, which could be made available in September. In this week's episode, I speak with Dr. Christopher Doehring, vice president of medical affairs at Franciscan Health, to get his reaction to the news.